The FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) meets in open session at 8:30 a.m. ET on May 28 to discuss and make recommendations on the selection of the 2026–2027 formula for COVID-19 vaccines in the United States.
…
editor's pick
latest video
news via inbox
Nulla turp dis cursus. Integer liberos euismod pretium faucibua
